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Abstract
The results from association studies are usually summarized by a measure of evidence of
association (frequentist or Bayesian probability values) that does not directly reflect the impact of
the detected signals on familial aggregation. This article investigates the possible advantage of a two-
dimensional representation of genetic association in order to identify polymorphisms relevant to
disease: a measure of evidence of association (the Bayes factor, BF) combined with the estimated
contribution to familiality (the attributable sibling relative risk, ls). Simulation and data from the
North American Rheumatoid Consortium (NARAC) were used to assess the possible benefit
under several scenarios. Simulation indicated that the allele frequencies to reach the maximum BF
and the maximum attributable ls diverged as the size of the genetic effect increased. The
representation of BF versus attributable ls for selected regions of NARAC data revealed that SNPs
involved in replicated associations clearly departed from the bulk of SNPs in these regions. In the
12 investigated regions, and particularly in the low-recombination major histocompatibility region,
the ranking of SNPs according to BF differed from the ranking of SNPs according to attributable ls.
The present results should be generalized using more extensive simulations and additional real data,
but they suggest that a characterization of genetic association by both BF and attributable ls may
result in an improved ranking of variants for further biological analyses.
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Introduction
Susceptibility to rheumatoid arthritis (RA) is determined
by both genetic and environmental factors, with an
estimated sibling relative risk of 5-10. The HLA-DRB1
and PTPN22 genes explain approximately 50% of the
familial aggregation. A recent genome-wide association
(GWA) study carried out by the Wellcome Trust Case
Control Consortium (WTCCC) found nine single-
nucleotide polymorphisms (SNPs) with associated prob-
ability values of less than 10-5 that did not map to loci
previously related to RA [1]. In agreement with the
common disease-common variant hypothesis, the novel
variants were common (minor allele frequencies from
0.07 to 0.41) and they showed genotype relative risks
(GRRs) of less than 2.3. The authors of the WTCCC
article recognized a disparity between the large popula-
tion-attributable fraction (PAF) and the modest sibling
relative risk (ls) explained by the newly identified
variants [1]. This disparity is related to the technical
characteristics of the platforms used in GWA studies,
designed to scrutinize polymorphisms (common variants).
Let us assume that a polymorphism is a marker of a rarer
causal variant, and the marker-specific PAF equals the
PAF of the causal variant. Under this assumption, we
have demonstrated that the causal variant has a higher
attributable ls than the marker [2]. In other words: for a
fixed PAF, causal variants contribute more to familial
aggregation (ls) than the polymorphisms they are
represented by.
There is much debate concerning the representation of
statistical evidence in GWA studies. The frequentist p-
value depends on the power of the study and it does not
provide a consistent measure of evidence because
identical p-values do not imply identical evidence of
genetic association [3]. In contrast, the Bayes factor (BF)
statistic provides a single measure of the strength of
evidence of association.
We hypothesize here that the representation of genetic
association by BF together with the attributable ls may
help to identify polymorphisms relevant to RA, and use
simulation and data from the North American Rheuma-
toid Consortium (NARAC) to evaluate this assumption.
Methods
Derivation of attributable risks and Bayes factors
The sibling relative risk (ls) attributable to a gene reflects
the extent to which a particular genetic locus contributes
to familial aggregation. The calculation of attributable ls
values was first described in an early paper of James [4].
If the frequency of the high-risk allele is denoted by RAF,
the relative risk of RA for high-risk allele homozygotes
compared to low-risk allele homozygotes by GRRhom,
the relative risk of heterozygotes compared to low-risk
allele homozygotes by GRRhet and the disease prevalence
among low-risk allele homozygotes by 0, the attribu-
table ls is given by: ls = 1+(1/2Va+1/4Vd)/K2, where
Va (additive genetic variance divided by 0
2) equals
2RAF(1-RAF)[(1-RAF)(1-GRRhet)-RAF(GRRhom-GRRhet)]
2,
Vd (dominance genetic variance divided by 0
2) equals
RAF2(1-RAF)2[1+GRRhom-2GRRhet]
2 and K (population
prevalence divided by 0) equals RAF
2GRRHom+2RAF(1-
RAF)GRRhet+ (1-RAF)
2. Note that if the overall disease
prevalence is 50%, ls cannot exceed two by definition.
However, an important property of the attributable ls is that
it only depends on RAF, GRRhom, and GRRhet. That is, the
attributable ls is independent of the disease prevalence
among low-risk homozygotes 0.
The BF statistic is the ratio of the probability of the
observed data under the assumption that there is a true
association to its probability under the null hypothesis
(absence of association). A small BF provides evidence in
favor of a true association. To investigate the relationship
between attributable ls and the BF, we calculated the
expected distribution of genotypes in 1000 cases and
1000 controls when GRRhom = 1.5, 2, 3, 4, 5 and 10.
Calculations were carried out for the dominant model,
which assumes that GRRhet = GRRhom, the recessive
model (GRRhet = 1), and for the additive model (GRRhet =
(1+GRRhom)/2). Under Hardy-Weinberg equilibrium, the
expected distribution of genotypes in controls (D = 0) is:
Pr(G = aa|D = 0) = (1-RAF)2; Pr(G = Aa|D = 0) = 2RAF(1-
RAF); Pr(G = AA|D = 0) = RAF2 The expected distribution
of genotypes in cases (D = 1) satisfies:
GRRhom = (Pr(D = 1 | G = AA)/Pr(D = 0 | G = AA))/
(Pr(D = 1 | G = aa)/Pr(D = 0 | G = aa)) and GRRhet =
(Pr(D = 1 | G = Aa)/Pr(D = 0 | G = Aa))/(Pr(D = 1 | G =
aa)/Pr(D = 0 | G = aa)). For example, if RAF = 0.2 and
GRRhom = GRRhet = 2 (dominance), the expected distri-
bution is (aa = 640, Aa = 320, AA = 40) in controls and
(aa = 471, Aa = 471, AA = 59) in cases.
The expected distributions of genotypes were investi-
gated by Bayesian logistic regression. We considered a
general three-genotype model of association. Calculation
of BFs requires assumptions about effect sizes. We
assumed N(0,1) priors on the mean and the two genetic
effects. The function MCMClogit (R package MCMCpack
[5]) was used to generate a 10,000 sample dataset from
the posterior distribution using a random walk Metro-
polis algorithm. The BayesFactor function in the same
package was used to compute log marginal likelihoods
for a model ‘with’ compared to a model ‘without’
genotypic information using a Laplace approximation.
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Investigated regions
This study investigated regions around the 12 signals
detected in the WTCCC study with associated probability
values of less than 10-5 (Table 1). The left side of Table 1
represents the 12 selected regions from theWTCCC study.
For example, the most associated marker on 1p13 was
rs6679677. We retrieved NARAC data from 1000-kb
regions centred on the positions of the 12 signals from the
WTCCC study. For example, our first region comprised
the chromosomal interval (10,901,850::11,901,850)
around rs6679677. The WTCCC study reported two
SNPs in 6p21 that resulted in two overlapping intervals
which were independently investigated.
Calculation of attributable risks and Bayes factors for
NARAC data
SNPs in the 12 selected intervals were extracted from
NARAC data, and the association between RA and the
retrieved SNPs was represented by 1) the base 10
logarithm of the BF (log10BF) and 2) the attributable ls.
RA status (affected or unaffected) was modelled by
logistic regression, taking into account the covariates
gender, number of HLA-DRB1 shared-epitope alleles
(NN = 0, SN = 1 or SS = 2) and genotype (three levels).
Individuals withmissing information were excluded from
the calculations. Only SNPs with the three genotypes
represented in both cases and controls were considered.
As already mentioned, calculation of BFs requires
assumptions on effect sizes. We calculated frequentist
estimates of logistic regression coefficients over the
corresponding entire chromosomes using NARAC data.
Density plots and tests of goodness of fit of frequentist
estimates of log10GRRHom and log10GRRHet for the seven
investigated chromosomes indicated that GRR variation
was better represented by the median absolute deviation
(MAD) than by the standard deviation (data not shown).
Therefore, we assumed N(0, MAD2) priors on the
logarithms of genetic effects. MCMClogit and BayesFactor
[5] were used to calculate BFs for each SNP in the selected
regions based onNARAC data. The number of individuals
with complete data and the observed allele frequencies in
controls were used to draw 10,000 samples from a
binomial distribution, which were combined with the
posterior estimates of genetic effects to simulate the
distribution of attributable ls for each SNP.
A bagplot is a bivariate generalization of the non-
parametric univariate boxplot [6]. In a bagplot, the
region which contains 50% of the observations with
greatest bivariate depth is denominated the bag. Obser-
vations outside the bag expanded three times are
considered outliers, they are too far away from the
data’s central bulk. These outliers are indicated by closed
dots in univariate boxplots. Bagplots have been shown
to be equivariant for linear transformations and not
limited to elliptical distributions. Due to these properties
and the characteristics of our data (unknown shape of
the underlying distributions), we used non-parametric
bagplots to identify deviating SNPs. Bagplots were
determined using the function compute.bagplot in the R
package aplpack [7].
Table 1: Description and results from the 12 investigated regions
WTCCC studya NARAC datab
Chr SNP Position MAD of log10 Outlying SNPs, gene regions log10 (BF) RAF ls Median (5th-95th)
GRRhom GRRhet
1p13 rs6679677 11,401,850 0.282 0.199 rs2476601, PTPN22 3.91 0.084 1.048 (1.017-1.098)
1p36 rs6684865 2,578,391 0.282 0.199 - - - -
1p31 rs11162922 80,284,079 0.282 0.199 - - - -
4p15 rs3816587 25,093,513 0.255 0.188 rs12505556, SLC34A2 3.04 0.112 1.071 (1.011-1.630)
6p21a rs6457617 32,771,829 0.306 0.206 rs2395175, MHC 16.48 0.148 1.164 (1.108-1.241)
rs7765379, MHC 6.11 0.113 1.175 (1.053-1.668)
6p21b rs615672 32,682,149 0.306 0.206 rs2395175, MHC 16.48 0.148 1.164 (1.108-1.241)
rs7765379MHC 6.11 0.113 1.175 (1.053-1.668)
6q23 rs6920220 138,048,197 0.306 0.206 - - - -
7q32 rs11761231 130,827,294 0.268 0.185 - - - -
10p15 rs2104286 6,139,051 0.290 0.197 - - - -
13q12 rs9550642 19,848,092 0.286 0.200 rs1407961, ZMYM2 3.59 0.920 1.033 (1.033-1.225)
21q22 rs2837960 41,433,788 0.288 0.208 rs468646, MX1 4.28 0.488 1.038 (1.019-1.057)
rs466092, MX2 3.59 0.488 1.030 (1.016-1.048)
22q13 rs743777 35,876,107 0.283 0.216 rs3218258, IL2RB 9.63 0.771 1.061 (1.041-1.084)
rs710183, CSF2RB 4.26 0.072 1.028 (1.011-1.183)
rs8137446, KCTD17 3.48 0.903 1.035 (1.018-1.123)
aResults from the WTCCC study.
bResults based on NARAC.
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Results
Theoretical relationship between Bayes factor and
attributable risk
Table 1 shows the RAFs at which the maximum log10BF
and ls were reached assuming several GRRhom values
under the dominant, recessive and additive modes of
inheritance. For example, under GRRhom = 2 and
dominance, the maximum log10BF (25.3) was reached
when RAF = 0.22 and the maximum ls (1.06) for RAF =
0.17. Alternative sample-sizes/priors would result in
different log10BFs, but the RAF to reach the maximum
log10BF would not change. The representation of log10BF
versus attributable ls (data not shown) indicated that
the two parameters were correlated, but they did not
correspond one-to-one. In the three models, the RAF
corresponding to the highest attributable ls and the RAF
corresponding to the highest log10BF decreased with
increasing GRRhom values. The RAF at maximum log10BF
was always higher than the RAF at maximum ls, i.e.,
balanced designs resulted in stronger association evi-
dences. The difference between RAF at maximum log10BF
and RAF at maximum attributable ls increased with
increasing GRRhom, for example (0.24-0.21) = 0.03 if
GRRhom = 1.5 versus (0.14-0.05) = 0.09 when GRRhom =
10 in the dominant model.
Bayes factors and attributable sibling relative risks
in the investigated regions
The analysis of complete chromosomes by frequentist
logistic regression resulted in 2(GRRhom, GRRhet) × 8
(chromosomes 1, 4, 6, 7, 10, 13, 21, 22) sets of genetic
effects. Table 1 shows the MADs of log10GRRhom and
log10GRRhet used as scale parameters in the normal prior
distributions. As expected, the a priori variance of genetic
effects was highest for chromosome 6 (MHC region).
Figure 1 represents the bivariate distribution of log10BF
by attributable ls based on NARAC data for individual
SNPs in the 12 explored regions. Gray points show SNPs
within the bulk of data, outlying observations (observa-
tions outside the bag expanded three times) are
represented by black points. The right part of Table 1
shows SNP numbers and close genes for the most
extreme outliers. For example, rs2476601 in the 1p13
region: based on NARAC data, the log10BF was 3.91, the
high-risk allele frequency in controls is 0.084, and the
estimated attributable ls with 95% confidence interval
was 1.048 (1.017 to 1.098) for this SNP. The other two
regions on chromosome 1 did not reveal strong
associations with RA. The investigation of the two
overlapping intervals in chromosome 6p21 showed
practically identical results; the highest attributable ls
values were found for SNPs rs7765379 (1.175) and
rs2395175 (1.164). Many SNPs in this region showed a
strong association with RA. The investigation of the
6q23, 7q32, and 10p15 regions resulted in log10BF
values below three. The log10BF and the attributable ls
for SNP rs1407961 in the 13q12 region clearly departed
from the majority of data. Two extreme outlier SNPs
were identified in the 21q22 region and three outliers in
the 22q13 region.
Discussion
This study explored the advantage of combining BF, a
measure of statistical evidence of association, and the
attributable ls, a measure of contribution to familial
aggregation, in order to characterize the effect of a
particular polymorphism on disease risk. Both simula-
tion and NARAC-based results showed that BF usually
correlates with the attributable ls. Most markers identi-
fied in GWA studies confer a slightly increased risk of
disease. For this kind of modest genetic effects (GRR ≤
2), simulation indicated that the maximum log10BF and
the maximum attributable ls were expected to be found
for variants with similar frequencies: around 20%
(dominant), 40% (additive) and 70% (recessive pene-
trances). The larger the size of the genetic effect, the
lower the RAF to reach the maxima, and the larger the
difference between RAFs. Causal variants generally show
stronger effects than markers from GWA studies. For
example, a recent GWA study identified five novel breast
cancer susceptibility loci. The highest GRR was 1.6,
which can be compared with GRR = 6 to 30 for carriers of
BRCA1 mutations. Simulation suggested that, for this
kind of strong genetic effects, attributable ls and BF are
two different dimensions.
Table 2: Allele frequencies at maximum ls and maximum log10(BF)
Dominant model Recessive model Additive model
GRRhom Max log10(BF) Max ls Max log10(BF) Max ls Max log10(BF) Max ls
1.5 0.24 0.21 0.70 0.66 0.39 0.40
2 0.22 0.17 0.64 0.61 0.38 0.33
3 0.20 0.13 0.61 0.54 0.33 0.25
4 0.17 0.10 0.59 0.48 0.26 0.20
5 0.16 0.08 0.57 0.45 0.24 0.17
10 0.14 0.05 0.49 0.33 0.17 0.09
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The representation of ls versus log10BF based on NARAC
data confirmed that SNPs which have shown replicated
associations clearly departed from the majority of
polymorphisms in the selected regions. For example,
the functionally relevant SNP rs2476601 was unequi-
vocally separated from the rest of SNPs in the 1p13
region. Other genes located in the proximity of the most
extreme SNPs were ZMYM2, MX1, MX2, IL2RB, and
CSF2RB. This list includes SNPs which show strong
evidence of association (log10BF higher than three) and
outlying ls values. SNPs with high attributable ls values
but relatively low BFs may also be of interest. Simulation
showed that one BF value corresponds to two different ls
values. In the 12 regions investigated using NARAC data,
the ranking of SNPs according to BF differed from the
ranking according to attributable ls. The difference was
particularly clear in the low-recombination MHC region,
where rs7765379 showed the maximum ls and
rs2395175 showed the maximum log10BF. This
difference in rankings suggests that, in addition to a
measure of association evidence, the extensive fine-
mapping needed to characterize etiological variants may
benefit from the consideration of the attributable ls.
Future studies based on more extensive simulations and
additional real data should investigate this possibility.
The present study made use of Bayesian and robust
statistics. The Bayesian approach has been overlooked in
the analysis of GWA studies, where the adjustment for
multiple testing, the relationship between power and
statistical significance, and the selection of disease
models are important issues [1,3]. We only considered
SNPs with the three genotypes represented in both cases
and controls. This strategy would initially hamper the
identification of rare causal variants but, on the other
hand, logistic regression has not been robust to
particular types of outliers, and a three-genotype model
with well represented categories would result in more
Figure 1
Scatterplots of log10 values of Bayes factors (log10(BF)) and attributable sibling relative risks (ls) for SNPs in
the investigated regions. Outlying SNPs (black points) were identified by bagplots. SNP numbers are shown for most
extreme outliers with log10(BF)s higher than three. Note scale differences.
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robust estimates. Robust methods aim to describe the
structure best fitting to the bulk of the data, and to
identify deviating observations. Robust statistics are used
a lot less than they ought to be in genetic epidemiology.
The use of MADs and bagplots in the present article
illustrates their advantage over classical methods in
practical situations.
Conclusion
The association results from GWA studies are usually
summarized by a measure of evidence of association
(frequentist or Bayesian probability values), which do
not reflect the contribution of the identified signals to
familial aggregation. We propose here a two-dimen-
sional characterization of genetic association consisting
of the attributable ls and the BF.
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